Why the study?
Does combination chemotherapy with CAF improve response rates in patients with metastatic breast carcinoma?
Population
26 patients with metastatic breast carcinoma who had measurable sites of disease
Design
Cohort
Follow-up
30 months
Authors
Loading...
May support CAF in metastatic breast carcinoma; leaves open need for randomized confirmation of benefit.
Does combination chemotherapy with CAF improve response rates in patients with metastatic breast carcinoma?
CAF combination chemotherapy demonstrates a high response rate and prolonged survival in patients with metastatic breast carcinoma.
Dalley et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: